Generic Drugs (eBook)

The Pay-for-Delay Problem

Christina M Curtin (Herausgeber)

eBook Download: PDF

2017
136 Seiten
Nova Science Publishers (Verlag)
978-1-61122-360-6 (ISBN)

Infos

Brand-name pharmaceutical companies can delay generic competition that lowers prices by agreeing to pay a generic competitor to hold its competing product off the market for a certain period of time. These so-called "e;pay-for-delay"e; agreements have arisen as part of patent litigation settlement agreements between brand-name and generic pharmaceutical companies. "e;Pay-for-delay"e; agreements are "e;win-win"e; for the companies: brand name pharmaceutical prices stay high, and the brand and generic share the benefits of the brand's monopoly profits. Consumers lose, however: they miss out on generic prices that can be as much as 90 percent less than brand prices. For example, brand-name medication that costs $300 per month, might be sold as a generic for as little as $30 per month. This book examines the "e;pay-for-delay' program and how drug company pay-offs cost consumers billions.

Produkt-Details

• Erscheint lt. Verlag: 1.2.2017
• Themenwelt: Medizin / Pharmazie ► Pharmazie
• Themenwelt: Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung
• Themenwelt: Technik
• Themenwelt: Wirtschaft
• ISBN-10: 1-61122-360-1 / 1611223601
• ISBN-13: 978-1-61122-360-6 / 9781611223606